Wisdom Angels

A SEBI registered Category I Alternative Investment Fund (AIF) dedicated to investing in India’s emerging needs in Healthcare, Wellness and Nutrition

India spends way below global average on healthcare, and compared to other large economies. As India transitions into a high income country, Healthcare and allied sectors – Wellness & Nutrition – are set to be the fastest growing section of consumer demand. Healthcare sector will grow faster than GDP by 3-4% over several decades.

Wisdom Angels

A SEBI registered Category I Alternative Investment Fund (AIF) dedicated to investing in India’s emerging needs in Healthcare, Wellness and Nutrition

India spends way below global average on healthcare, and compared to other large economies. As India transitions into a high income country, Healthcare and allied sectors – Wellness & Nutrition – are set to be the fastest growing section of consumer demand. Healthcare sector will grow faster than GDP by 3-4% over several decades.

About US

Wisdom Angels has been co-sponsored by Wisdomsmith Advisors LLP, an advisory focussed with pharma/healthcare, more commonly called ‘Lifesciences’, as its main focus area. The fund has another co-sponsor: a family office of a pharma company promoter.

The partners of Wisdomsmith associated with the fund have considerable transaction and consulting experience in the Lifesciences sector. We have worked with clients in growth strategies, India entry strategy, and business planning and monitoring and fund raising. This gives us considerable ability to evaluate investment proposals on key parameters like team quality, viability and uniqueness of business model, growth potential and exit possibilities.

Venture capital investing in Lifesciences is a specialised field. Globally, the angel to Series B investment space in Lifesciences, is dominated by sector focussed fund. We are inspired by the model and seek to emulate this.

Team

Our Investment team and Advisory committee has considerable research and investing experience in healthcare and allied sectors

Investment Management

Ajay Jindal

ajay@wisdomsmith.com

Ajay has two decades of equity research, investment banking and PE investing, with over 10 years in leadership roles. With The Times of India group

Anil Khanna

anil@wisdomsmith.com

With over 20 years of experience, Anil is among India’s foremost strategic marketing experts in pharma and healthcare. He has led multiple strategic

Pashupatinath Ajit Verma

ajit@wisdomsmith.com

Ajit has over 27 years of experience in the financial services sector in various capacities with leading Indian and MNCs,which include TCS, Lazard


Investment Advisory Committee

Gautam Khanna

Mr. Gautam Khanna has over 28 years of experience in the healthcare industry. He is currently the CEO of P.D. Hinduja Hospital and Medical

Anurag Gupta

Mr. Anurag Gupta has over 25 years of experience in the healthcare industry. Currently he is with Tata Trusts, and is spearheading their National

Dr.Chirantan Chatterjee

Dr Chatterjee is an economist with interests in applied microeconomics, economics of innovation and

Dr Chaitanya Saxena

Dr Saxena is the founder and CEO of Shantani Proteome Analytics Pvt. Ltd, a company which develops and commercializes drug target deconvolution

Portfolio

INVESTMENT STRATEGY

Investment Thesis

  • We are not trying to be ‘jack-of-all’. We believe focussed funds is the way to go.
  • India has few sector focussed funds reflects the nascent stage of the market. In contrast, sector focussed funds dominate Angel / Series A / Series B stage transactions in Developed markets like US. Generalist funds tend to come in only at mid / late stage
  • Healthcare / Lifesciences space in the US has dozens of specialist funds, while in India there are very few. See Annexure for a list
  • Our advisors have decades of sector experience
  • This is bolstered by investors who are CXOs and business owners in healthcare and related areas
  • Our partners have business consulting experience with leading MNC and India pharma and healthcare companies
  • Our partners have also helped healthcare companies raise funding, and are well connected with other healthcare investors

Investment Parameters and Criteria

  • Revenue history of atleast one year preferable
  • A unique differentiation – either in product, or IP,
  • Business can be B2C or B2B. If B2B, should be scope to
  • Capable founding team with right experience, skillset
  • We expect to be the first external investors. We will be happy to collaborate with other funds.
  • Our initial investment size would be in the range of Rs 1-2.5 crore.

Expected Strategy Outcomes

Better Deal Flow

Given our sector focus, we expect to emerge as ‘Investor of Choice’ for startups in healthcare and allied areas

Better Selection

The cumulative sector expertise of the investment manager, advisory committee and anchor investors to ensure better selection of investment targets

Better Monetoring

Our investors and advisors have the weight of experience to provide right guidance, and open the right doors for business connections for our startups

Better Follow On Funding

We are well networked with investors who do Series A / B and more in the healthcare space

Better Exit Possibilities

We expect to able to find strategic exit possibilities utilising our network of advisors and investors

Knowledge Centre


Global Healthcare PE Deal Tracker.

Our Location

Coordinates for abs potioning the closest positioned parent box of the positioned abs qoning the closes for abs potioning the closest positioned parent.

Office Location

307, Durian Industrial Estate, Goregaon Mulund Link Road, Near Pravasi Industrial Estate, Goregaon East, Mumbai 400063, Maharashtra

Corporate Email

admin@wisdomsmith.com